AJMC September 4, 2024
According to some reports, the draft rule imposes strict limitations on telehealth prescriptions even as advocates push for extension of current flexibilities.
The Drug Enforcement Administration (DEA) is nearing the final stages of its rulemaking process for prescribing controlled substances via telehealth, but leaked details reveal a more restrictive approach than anticipated.1
While advocates are once again lobbying the White House and Congress to extend a waiver on the use of telemedicine to prescribe medications, leaked details suggest this prescribing route will be limited, according to anonymous sources speaking to Fierce Healthcare and Politico.1,2
The telehealth prescribing flexibility rule has been used since 2020 to prescribe medications for conditions such as substance abuse disorder and attention deficit disorder. Last year,...
Today's Sponsors
Today's Sponsor